New Drug Being Evaluated for Patients with Squamous Cell Cancer of the Lung
Lung Cancer, News
Boehringer Ingelheim recently announced that its product Giotrif/Gilotrif (generically known as afatinib) has been accepted for final review by the US Food and Drug Administration and the European Medicines Agency for the ... Read more